Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's Lesions

NCT02395042 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02395042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02395042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's Lesions
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
April 15, 2015
Completion date
November 20, 2017
Enrollment
59 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cystitis, interstitial, ulcer